{"topic":{"0":"Tonix Pharmaceuticals","1":"Tonix Pharmaceuticals","2":"Tonix Pharmaceuticals","3":"Tonix Pharmaceuticals","4":"Tonix Pharmaceuticals","5":"Tonix Pharmaceuticals","6":"Tonix Pharmaceuticals","7":"Tonix Pharmaceuticals","8":"Tonix Pharmaceuticals","9":"Tonix Pharmaceuticals","10":"Tonix Pharmaceuticals","11":"Tonix Pharmaceuticals","12":"Tonix Pharmaceuticals"},"dialog_lvl":{"0":"model","1":"model","2":"model","3":"model","4":"model","5":"model","6":"model","7":"model","8":"model","9":"model","10":"model","11":"model","12":"model"},"role":{"0":"Explainer","1":"Explainee","2":"Explainer","3":"Explainee","4":"Explainer","5":"Explainee","6":"Explainer","7":"Explainee","8":"Explainer","9":"Explainee","10":"Explainer","11":"Explainee","12":"Explainer"},"turn_num_tokens":{"0":13,"1":4,"2":37,"3":4,"4":57,"5":5,"6":27,"7":4,"8":38,"9":7,"10":13,"11":7,"12":69},"turn":{"0":"Hi, I'm your automated assistant. I can answer your questions about Tonix Pharmaceuticals.","1":"What is Tonix Pharmaceuticals?","2":"Tonix Pharmaceuticals Tonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in New York City that focuses on repurposed drugs for central nervous system conditions and as of 2016 was also pursuing a biodefense project.","3":"When was it founded?","4":"The company's predecessors were Tamandare Explorations Inc. which had been formed in 2007 as a mining wildcat vehicle focused on land in Nevada and the shares of which were traded over the counter, and L & L Technologies, LLC, which had been formed in 1996 by Seth Lederman and Donald Landry to repurpose drugs for CNS development.","5":"What is unique about it?","6":"L&L had formed Janus Pharmaceuticals, Inc., which later became Vela Pharmaceuticals, Inc. to develop some of its inventions, and Vela returned those assets to L&L in 2006.","7":"Any other interesting information?","8":"L&L placed them in a subsidiary called Krele Pharmaceuticals, Inc., and that subsidiary and Tamandare Explorations Inc. performed a reverse merger in October 2011; the new entity was renamed Tonix Pharmaceuticals Holding Corp. and Lederman was named CEO.","9":"Is it listed on any stock exchanges?","10":"It was listed on the NASDAQ exchange in 2013 under the symbol TNXP.","11":"What are some of its lead products?","12":"As of 2013 its lead candidates were a reformulation of cyclobenzaprine as a tablet for sublingual administration called TNX-102 SL (formerly called VLD-cyclobenzaprine and then KRL-102), which was under development for fibromyalgia and with preclinical efforts underway for posttraumatic stress disorder, TNX-201 (a single-racemate formulation of isometheptene mucate the company was considering for some headaches), and TNX-301, (a combination drug with disulfiram and selegiline for treatment for alcohol abuse)."}}